NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy after chemo may keep High-Risk lymphoma at bay
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab after standard chemotherapy can help prevent relapse in people with high-risk diffuse large B-cell lymphoma. About 109 adults who achieved complete remission after initial treatment received atezolizumab as a con…
Matched conditions: NHL
Phase: PHASE2 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
New drug cocktail shows promise in slowing lymphoma growth
Disease control OngoingThis study tests whether combining copanlisib and rituximab can slow or stop the growth of follicular lymphoma, a type of blood cancer. About 33 adults who have not yet been treated for their disease will receive the drugs through an IV over up to 13 cycles. The main goal is to s…
Matched conditions: NHL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:40 UTC